FasL expression on pig cells suppresses human natural killer cell mediated-cytotoxicity.
Nakajima
H
H
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Fujiwara
I
I
Matsuda
T
T
Mizuta
N
N
Yamagishi
H
H
Oka
T
T
Yoshimura
N
N
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity; D002478:Cells, Cultured; D053222:Fas Ligand Protein; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D008562:Membrane Glycoproteins / Q000235:genetics / Q000276:immunology*; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors / Q000494:pharmacology; D011994:Recombinant Proteins / Q000276:immunology; D013552:Swine; D014162:Transfection; D014183:Transplantation, Heterologous / Q000276:immunology*
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D007376:Interleukin-2; D008562:Membrane Glycoproteins; D011480:Protease Inhibitors; D011994:Recombinant Proteins; D008666:Metalloendopeptidases